The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States

Breast Cancer Research and Treatment

Volumn 85, Issue 3, 2004, Pages 219-222

  Schootman, Mario ^a,b   Jeffe, Donna ^a,b   Reschke, Anat ^a,b   Aft, Rebecca ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Screening; Stage at diagnosis; Trend

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; UNITED STATES; BREAST TUMOR; HEALTH SURVEY; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIOGRAPHY; UTILIZATION REVIEW;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; UNITED STATES;

EID: 3042667034     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000025410.41220.67     Document Type: Article

References (23)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002
2. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL: Efficacy of screening mammography: a meta-analysis. JAMA 273: 149-254, 1995
3. van den Akker-van Marle E, de Koning H, Boer R, van der Maas P: Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom. J Med Screen 6: 30-34, 1999
4. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC: The natural history of breast carcinoma. What have we learned from screening? Cancer 86: 449-462, 1999
5. Feig SA: Effect of service screening mammography on population mortality from breast carcinoma. Cancer 95: 451-457, 2002
6. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R: Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93: 1704-1713, 2001
7. Norden T, Thurfjell E, Hasselgren M, Lindgren A, Norgren A, Bergstrom R, Holmberg L: Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer 33: 624-628, 1997
8. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30: 187-210, 1992
9. Dongen JA: The usefulness of screening data for studying the biology of breast cancer. Eur J Cancer 33: 519-520, 1997
10. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK: Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer 81: 877-880, 1999
11. McCann J, Stockton D, Day N: Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 5: 42-48, 1998
12. Schouten LJ, De Rijke JM, Schlangen JT, Verbeek AL: Evaluation of the effect of breast cancer screening by record linkage with the cancer registry. J Med Screen 5: 37-41, 1998
13. Hakama M, Pukkala E, Heikkila M, Kallio M: Effectiveness of the public health policy for breast cancer screening in Finland: population-based cohort study. BMJ 314: 864-867, 1997
14. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK: Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88: 1571-1579, 1996
15. Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, Edwards BK: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824-842, 2001
16. Day NE, Williams DRR, Khaw KT: Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59: 954-958, 1989
17. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Muiphy GP, Sullivan BO, Sobin LH, Yarbro JW: AJCC Cancer Staging Manual. 5th edn, Lippincott-Raven, Philadelphia, 1997
18. Miller AB, To T, Baines CJ, Wall C: Candian national breast screening study-2: 13-year results of a randomized trial in women age 50-59 years. J Natl Cancer Inst 92: 1490-1499, 2000
19. Paci E, Giorgi D, Bianchi S, Vezzosi V, Zappa M, Crocetti E, Rosselli del Turco M: Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 38: 568-573, 2002
20. Peto R, Boreham J, Clarke M, Davies C, Beral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355: 1822, 2000
21. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-1998: comparison of observed with predicted mortality. BMJ 321: 665-669, 2000
22. Novadex Adjuvant Trial Organization: Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Lancet I: 257-261, 1983
23. Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1-15, 71-85, 1992